Pharmacokinetics and bioequivalence of Simvastatin Tablets in healthy volunteers
Yinbo Li
Abstract
Yinbo Li
Abstract
Objective:To study the pharmacokinetics and bioequivalence of Simvastatin Tablets in Chinese healthy volunteers. Methods:The plasma concentrations of Simvastatin in 20 healthy male volunteers were determined by LC-MS method after being orally administered with single dose of 40 mg Simvastatin Tablets by randomized crossover way;the pharmacokinetic parameters and the relative bioequivalence of the two preparations of Simvastatin were calculated by DAS Ver 2.0 software. Results:The main pharmacokinetic parameters of Simvastatin were as follows:Cmax were(5.58±3.81) and(4.97±2.84) ng/ml;tmax were(1.58±0.49) and(1.93±0.67) h;t1/2 were(5.74±4.55) and(5.75±4.81) h;AUC0-t were(18.40± 11.65) and(19.74±10.53) ng/(h·ml) ;AUC0-∞ were(24.03±18.91) and(26.62±20.05) ng/(h·ml) for the test preparation and the reference preparation,respectively;the 90% confidence interval of AUC0-t,AUC0-∞ and Cmax of the test preparation were 84.2%-99.3%,85.5%-100.8% and 95.9%-121.0%,respectively;the relative bioavailability of Simvastatin was(93.38±18.99) %. Conclusion:The results of the statistic analysis show that the test preparation and the reference preparation of Simvastatin Tablets are bioequivalent.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective:To study the pharmacokinetics and bioequivalence of Simvastatin Tablets in Chinese healthy volunteers. Methods:The plasma concentrations of Simvastatin in 20 healthy male volunteers were determined by LC-MS method after being orally administered with single dose of 40 mg Simvastatin Tablets by randomized crossover way;the pharmacokinetic parameters and the relative bioequivalence of the two preparations of Simvastatin were calculated by DAS Ver 2.0 software. Results:The main pharmacokinetic parameters of Simvastatin were as follows:Cmax were(5.58±3.81) and(4.97±2.84) ng/ml;tmax were(1.58±0.49) and(1.93±0.67) h;t1/2 were(5.74±4.55) and(5.75±4.81) h;AUC0-t were(18.40± 11.65) and(19.74±10.53) ng/(h·ml) ;AUC0-∞ were(24.03±18.91) and(26.62±20.05) ng/(h·ml) for the test preparation and the reference preparation,respectively;the 90% confidence interval of AUC0-t,AUC0-∞ and Cmax of the test preparation were 84.2%-99.3%,85.5%-100.8% and 95.9%-121.0%,respectively;the relative bioavailability of Simvastatin was(93.38±18.99) %. Conclusion:The results of the statistic analysis show that the test preparation and the reference preparation of Simvastatin Tablets are bioequivalent.
Key concepts: Bioequivalence, Simvastatin, Medicine, Cmax, Pharmacokinetics, Bioavailability, Confidence interval, Pharmacology